Kanser Hastalarında Sol Atriyal Apendiks Kapama

Paterson DI, Wiebe N, Cheung WY, Mackey JR, Pituskin E, Reiman A, Tonelli M. Incident cardiovascular disease among adults with cancer: a population-based cohort study. JACC Cardio Oncol 2022;4:85–94.

Giza DE, Iliescu G, Hassan S, Marmagkiolis K, Iliescu C. Cancer as a risk factor for cardiovascular disease. Curr Oncol Rep 2017;19:39.

Beyer AM, Bonini MG, Moslehi J. Cancer therapy-induced cardiovascular toxicity: old/new problems and old drugs. Am J Physiol Heart Circ Physiol 2019;317:H164–H167.

Fradley MG, Beckie TM, Brown SA, et al. Recognition, Prevention,and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association. Circulation. 2021;144(3):e41–55.

Farmakis D, Parissis J, Filippatos G. Insights into onco-cardiology: atrial fibrillation in cancer. J Am Coll Cardiol 2014;63:945–953.

Khamis A, Shaban AE, Altamimi TS, Shkoukani ZW, Hamam I. Atrial fibrillation in cancer patients who develop stroke. Cardiooncology 2022;8:12.

Melloni C, Shrader P, Carver J, Piccini JP, Thomas L, Fonarow GC, Ansell J, Gersh B, Go AS, Hylek E, Herling IM, Mahaffey KW, Yu AF, Peterson ED, Kowey PR, ORBIT-AF Steering Committee. Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry. Eur Heart J Qual Care Clin Outcomes 2017;3:192–197.

Murtaza M, Baig MMA, Ahmed J, Serbanoiu LI, Busnatu SS. Higher mortality associated with new-onset atrial fibrillation in cancer patients: a systematic review and meta-analysis. Front Cardiovasc Med 2022;9:867002.

Raposeiras Roubın S, Abu Assi E, Munoz Pousa I, Domınguez Erquicia P, Melendo Viu M, Gonzalez Bermudez I, Iniguez Romo A. Incidence and predictors of bleeding in patients with cancer and atrial fibrillation. Am J Cardiol 2022;167:139–146.

Sorigue, M., & Miljkovic, M. D. (2019). Atrial Fibrillation and Stroke Risk in Patients With Cancer: A Primer for Oncologists. Journal of oncology practice, 15(12), 641–650. https://doi.org/10.1200/JOP.18.00592

Kornej J, Borschel CS, Benjamin EJ, et al. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circ Res.2020;127:4–20.

Shapiro CL. Cancer survivorship. N Engl J Med. 2018;379(25):2438–2450.

Kumar, S., Yoon, S., Milioglou, I., Tashtish, N., Farmakis, I., Dallan, L. A. P., Mogalapalli, A., Arruda, M., & Filby, S. J. (2023). Left Atrial Appendage Closure Outcomes in Patients With Cancer at a Single Tertiary Center. The American journal of cardiology, 202, 176–181. https://doi.org/10.1016/j.amjcard.2023.06.068

Hobohm L, von Bardeleben RS, Ostad MA, Wenzel P, Munzel T, Gori T, Keller K. 5-year experience of in-hospital out comes after percutaneous left atrial appendage closure in Germany. JACC Cardiovasc Interv 2019;12:1044–1052.

Shabtaie, S. A., Tan, N. Y., Ward, R. C., Lewis, B. R., Yang, E. H., Holmes, D. R., Jr, & Herrmann, J. (2023). Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Cancer. JACC. CardioOncology, 5(2), 203–212. https://doi.org/10.1016/j.jaccao.2022.10.016

Isogai, T., Saad, A. M., Abushouk, A. I., Shekhar, S., Kuroda, S., Gad, M. M., Wazni, O. M., Krishnaswamy, A., & Kapadia, S. R. (2021). Procedural and Short-Term Outcomes of Percutaneous Left Atrial Appendage Closure in Patients With Cancer. The American journal of cardiology, 141, 154–157. https://doi.org/10.1016/j.amjcard.2020.12.003

Agarwal, S., Guha, A., Munir, M. B., DeSimone, C. V., Deshmukh, A., & Asad, Z. U. A. (2023). Outcomes of patients with cancer undergoing percutaneous left atrial appendage occlusion. Journal of interventional cardiac electrophysiology: an international journal of arrhythmias and pacing, 66(8), 1791–1794. https://doi.org/10.1007/s10840-023-01621-w